Buy Aurobindo Pharma, says Rahul Mohindar

Rahul Mohindar of viratechindia.com recommends buying Aurobindo Pharma.

Rahul Mohindar of viratechindia.com told CNBC-TV18, "The weakness is clearly among the banks. If you ask me as a short-term trader even now the front line banks look a little weak to me. If I am playing the next 4-5 percent, the banks are going to be weak. If you are trying to utilise this correction from a buy perspective selectively I would look at stocks like  Infosys  and  Tata Consultancy Services  (TCS)."

"I like technology, pharma sectors you want to be in probably use the drop to get in. So selectively this would be the sector I would really look at on the buy side. Technology and pharma look interesting to me. So something like Aurobindo Pharma  to be specific at these levels with Rs 1,120 stop makes a good buy. We have seen a sharp savage correction over the last 3-4 sessions. I think there is a lot of opportunity out there," he said.

Anda sedang membaca artikel tentang

Buy Aurobindo Pharma, says Rahul Mohindar

Dengan url

http://untukkesehatanda.blogspot.com/2015/03/buy-aurobindo-pharma-says-rahul-mohindar.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Buy Aurobindo Pharma, says Rahul Mohindar

namun jangan lupa untuk meletakkan link

Buy Aurobindo Pharma, says Rahul Mohindar

sebagai sumbernya